The global hair restoration market could reach $12.94 billion by 2030, according to The Business Research Company. The market could expand at a compound annual growth rate of 11.9% through 2030. The market grew from $7.37 billion in 2025 to $8.26 billion in 2026.
The report links this growth to greater demand for regenerative medicine and minimally invasive hair restoration procedures. Investment in robotic-assisted procedures is also supporting market expansion, alongside growing medical tourism for hair restoration. Data-driven treatment planning and personalised restoration approaches are also gaining importance across the sector.
Regenerative therapies shape market development
Companies are increasingly developing regenerative medicine products to address changing expectations around hair restoration. Scalp serums represent one emerging area, with manufacturers developing products designed to support scalp and follicle health.
In March 2024, BioPhotas introduced Restore Hair Serum alongside its Celluma Light Therapy device. The product combines peptides, vitamins and plant-based ingredients designed for scalp application.
The market is also seeing greater interest in robotic hair transplants and minimally invasive restoration techniques. Advances in regenerative and stem cell therapies could further influence treatment development during the forecast period.
Market segments continue to expand
The global hair restoration market includes surgical procedures such as follicular unit extraction and follicular unit transplantation. Follicular unit extraction includes manual, automated and robotic procedures.
Follicular unit transplantation includes strip harvesting and non-strip harvesting approaches. The therapy segment covers low-level laser therapy, stem cell hair restoration and platelet-rich plasma treatments. The market also segments demand by male and female consumers.
Strategic developments support industry growth
Major companies are investing in technologies and treatments across the hair restoration landscape. The industry includes pharmaceutical companies, medical device manufacturers, specialist clinics and biotechnology firms. In March 2023, Sun Pharmaceutical Industries acquired Concert Pharmaceuticals for an undisclosed amount.
The acquisition supports Sun Pharma’s efforts to advance deuruxolitinib for alopecia areata treatment. Concert Pharmaceuticals focuses on clinical biopharmaceutical therapies, including treatments targeting hair regrowth.
Technology remains central to future growth
The report identifies robotic procedures, regenerative therapies and personalised treatment planning among key market trends. Natural-looking results also remain an important focus for treatment providers and technology developers.
The combination of technological advances and changing treatment preferences could support continued market expansion through 2030. The Business Research Company expects the market to maintain strong growth as treatment options and technologies continue to evolve.